Literature DB >> 25366226

Microbial composition and antibiotic resistance of biofilms recovered from endotracheal tubes of mechanically ventilated patients.

Ilse Vandecandelaere1, Tom Coenye.   

Abstract

In critically ill patients, breathing is impaired and mechanical ventilation, using an endotracheal tube (ET) connected to a ventilator, is necessary. Although mechanical ventilation is a life-saving procedure, it is not without risk. Because of several reasons, a biofilm often forms at the distal end of the ET and this biofilm is a persistent source of bacteria which can infect the lungs, causing ventilator-associated pneumonia (VAP). There is a link between the microbial flora of ET biofilms and the microorganisms involved in the onset of VAP. Culture dependent and independent techniques were already used to identify the microbial flora of ET biofilms and also, the antibiotic resistance of microorganisms obtained from ET biofilms was determined. The ESKAPE pathogens play a dominant role in the onset of VAP and these organisms were frequently identified in ET biofilms. Also, antibiotic resistant microorganisms were frequently present in ET biofilms. Members of the normal oral flora were also identified in ET biofilms but it is thought that these organisms initiate ET biofilm formation and are not directly involved in the development of VAP.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25366226     DOI: 10.1007/978-3-319-11038-7_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Diagnostic Stewardship in the Pediatric Intensive Care Unit.

Authors:  Anna C Sick-Samuels; Charlotte Woods-Hill
Journal:  Infect Dis Clin North Am       Date:  2022-03       Impact factor: 5.982

2.  Oral health promotion in patients with chronic renal failure admitted in the Intensive Care Unit.

Authors:  Alexandre Franco Miranda; Erica Negrini Lia; Tatiane Maciel de Carvalho; Cinthia Gonçalves Barbosa de Castro Piau; Priscila Paganini Costa; Ana Cristina Barreto Bezerra
Journal:  Clin Case Rep       Date:  2015-11-09

Review 3.  Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices.

Authors:  Mohankandhasamy Ramasamy; Jintae Lee
Journal:  Biomed Res Int       Date:  2016-10-31       Impact factor: 3.411

4.  Eradication of P. aeruginosa biofilm in endotracheal tubes based on lock therapy: results from an in vitro study.

Authors:  María Jesús Pérez-Granda; María Consuelo Latorre; Beatriz Alonso; Javier Hortal; Rafael Samaniego; Emilio Bouza; María Guembe
Journal:  BMC Infect Dis       Date:  2017-12-04       Impact factor: 3.090

5.  Biofilm formation on three different endotracheal tubes: a prospective clinical trial.

Authors:  Hulda R Thorarinsdottir; Thomas Kander; Anna Holmberg; Sarunas Petronis; Bengt Klarin
Journal:  Crit Care       Date:  2020-06-29       Impact factor: 9.097

Review 6.  Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects.

Authors:  Antoni Torres; Anna Motos; Denise Battaglini; Gianluigi Li Bassi
Journal:  Crit Care       Date:  2018-12-17       Impact factor: 9.097

7.  Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China.

Authors:  Yu Wang; Rong Zhang; Wei Liu
Journal:  Infect Drug Resist       Date:  2018-11-13       Impact factor: 4.003

8.  Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection.

Authors:  Shasha Jiang; Berthony Deslouches; Chen Chen; Matthew E Di; Y Peter Di
Journal:  mBio       Date:  2019-04-09       Impact factor: 7.867

Review 9.  Membrane-Interacting Antifungal Peptides.

Authors:  Caroline Struyfs; Bruno P A Cammue; Karin Thevissen
Journal:  Front Cell Dev Biol       Date:  2021-04-12

Review 10.  NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Authors:  Yu-Ming Cai; Ying-Dan Zhang; Liang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 5.560

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.